PCM
DMII

PenderFund Capital Management’s Drugs Made In America Acquisition II Corp DMII Stock Holding History

PenderFund Capital Management’s Portfolio DMII Stock Details DMII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$800K Buy
79,500
+29,800
+60% +$299K 0.1% 72
2026
Q1 		$496K Buy
+49,700
New +$495K 0.08% 76

Other funds holding DMII

KIM
Karpus Investment Management Pittsford, New York $3.48B AUM 10.49% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
HCM
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
TCM
Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return

PenderFund Capital Management's DMII Position: Q2 2026 in Review

PenderFund Capital Management increased its Drugs Made In America Acquisition II Corp (DMII) stake by 60% in Q2 2026, buying an estimated $299K and bringing the position to 79,500 shares worth $800K. The position accounts for 0.1% of the portfolio, ranked #72.

PenderFund Capital Management first reported a position in DMII in Q1 2026 and has held it in 2 quarters since. 68 funds tracked by Wall St. Rank hold DMII as of Q2 2026.

  • PenderFund Capital Management held 79,500 shares of Drugs Made In America Acquisition II Corp worth $800K as of Q2 2026.
  • PenderFund Capital Management bought 29,800 Drugs Made In America Acquisition II Corp shares in Q2 2026, an estimated $299K.
  • Drugs Made In America Acquisition II Corp made up 0.1% of PenderFund Capital Management's portfolio in Q2 2026, its #72 holding.
  • PenderFund Capital Management first reported a position in Drugs Made In America Acquisition II Corp in Q1 2026 and has held it in 2 quarters since.
  • 68 funds tracked by Wall St. Rank held Drugs Made In America Acquisition II Corp as of Q2 2026.

Based on PenderFund Capital Management's 13F filing for Q2 2026, filed 17 Aug 2026.